WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis
- PMID: 26043867
- PMCID: PMC10666567
- DOI: 10.1002/14651858.CD004193.pub3
WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis
Abstract
This review has been withdrawn for the following reasons:
‐ a review author contravenes Cochrane's Commercial Sponsorship Policy. This policy ensures the independence of Cochrane reviews by making sure that there is no bias associated with commercial conflicts of interest in the conduct of Cochrane reviews. The author was employed by the biopharmaceutical company AstraZeneca and cannot say with certainty that the company did not produce or have any financial interest in the interventions in this review
‐ the review is substantially out of date
To view the published versions of this article, please click the 'Other versions' tab.
The editorial group responsible for this previously published document have withdrawn it from publication.
Update of
-
Anticholinergics for urinary symptoms in multiple sclerosis.Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004193. doi: 10.1002/14651858.CD004193.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 Jun 05;(6):CD004193. doi: 10.1002/14651858.CD004193.pub3. PMID: 19160231 Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
